Literature DB >> 11773863

Analysis of six SNPs of NAT2 in Ngawbe and Embera Amerindians of Panama and determination of the Embera acetylation phenotype using caffeine.

Lucia F Jorge-Nebert1, Michel Eichelbaum, Ernst-U Griese, Ted Inaba, Tomas D Arias.   

Abstract

Six NAT2 single-nucleotide polymorphisms (SNPs) were analysed in 105 unrelated Ngawbe and 136 unrelated Embera Amerindians (482 chromosomes) by SNP-specific polymerase chain reaction analysis. 282C>T was the most common synonymous mutation, while 857G>A was the most frequent nonsynonymous inactivating exchange. The allelic frequency of the NAT2*5 series (containing the 341T>C exchange) was 2.4% and 9.9% for Ngawbe and Embera, respectively, five- to 20-times lower than that in Caucasians. The NAT2*6 series (590G>A) showed allelic frequencies of 0% and 3.7%, eight- to 30-times lower than in Caucasians. On the other hand, the NAT2*7 series, characterized by mutation 857G>A, had allelic frequencies (23.3% and 22.8%) that were 10-20-times higher in Amerindians than in Caucasians. Amerindians are characterized by decreased genetic diversity because they display a low number of mutated alleles (four and five for Ngawbe and Embera, respectively) that are present at low proportions (27.6% and 39%), reduced genotypic variability (seven out of 15 and 12 out of 21 possible genotypes) and low heterozygosity (40% and 55.1%) at the NAT2 locus. The NAT2 phenotype was evaluated with caffeine in a subset of 72 Embera. There were no disagreements between genotype and phenotype among rapid and slow acetylators (13/72, 18%). We conclude that, in the Embera, the analysis of three inactivating mutations was sufficient in predicting the phenotype in more than 99.5% of these subjects. NAT2 would appear to be of a selectively neutral character given that there is no evidence of adaptation to the prevailing ecology in Amerindians.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11773863     DOI: 10.1097/00008571-200201000-00006

Source DB:  PubMed          Journal:  Pharmacogenetics        ISSN: 0960-314X


  8 in total

1.  Deciphering the ancient and complex evolutionary history of human arylamine N-acetyltransferase genes.

Authors:  Etienne Patin; Luis B Barreiro; Pardis C Sabeti; Frédéric Austerlitz; Francesca Luca; Antti Sajantila; Doron M Behar; Ornella Semino; Anavaj Sakuntabhai; Nicole Guiso; Brigitte Gicquel; Ken McElreavey; Rosalind M Harding; Evelyne Heyer; Lluis Quintana-Murci
Journal:  Am J Hum Genet       Date:  2006-01-13       Impact factor: 11.025

Review 2.  Pharmacogenetic research activity in Central America and the Caribbean: a systematic review.

Authors:  Carolina Céspedes-Garro; María-Eugenia G Naranjo; Fernanda Rodrigues-Soares; Adrián LLerena; Jorge Duconge; Lazara K Montané-Jaime; Hilda Roblejo; Humberto Fariñas; María de Los A Campos; Ronald Ramírez; Víctor Serrano; Carmen I Villagrán; Eva M Peñas-LLedó
Journal:  Pharmacogenomics       Date:  2016-09-16       Impact factor: 2.533

3.  Analysis of nucleotide diversity of NAT2 coding region reveals homogeneity across Native American populations and high intra-population diversity.

Authors:  S Fuselli; R H Gilman; S J Chanock; S L Bonatto; G De Stefano; C A Evans; D Labuda; D Luiselli; F M Salzano; G Soto; G Vallejo; A Sajantila; D Pettener; E Tarazona-Santos
Journal:  Pharmacogenomics J       Date:  2006-07-18       Impact factor: 3.550

4.  Expression of NAT2 in immune system cells and the relation of NAT2 gene polymorphisms in the anti-tuberculosis therapy in Mexican mestizo population.

Authors:  R Salazar-González; R Gómez; S Romano-Moreno; S Medellín-Garibay; A Núñez-Ruíz; M Magaña-Aquino; R C Milán-Segovia; D P Portales-Pérez
Journal:  Mol Biol Rep       Date:  2014-08-28       Impact factor: 2.316

5.  Interethnic diversity of NAT2 polymorphisms in Brazilian admixed populations.

Authors:  Jhimmy Talbot; Luiz Alexandre V Magno; Cinthia V N Santana; Sandra M B Sousa; Paulo R S Melo; Ronan X Correa; Giuliano Di Pietro; Fabrício Rios-Santos
Journal:  BMC Genet       Date:  2010-10-05       Impact factor: 2.797

6.  Inferring haplotypes at the NAT2 locus: the computational approach.

Authors:  Audrey Sabbagh; Pierre Darlu
Journal:  BMC Genet       Date:  2005-06-02       Impact factor: 2.797

7.  Worldwide distribution of NAT2 diversity: implications for NAT2 evolutionary history.

Authors:  Audrey Sabbagh; André Langaney; Pierre Darlu; Nathalie Gérard; Rajagopal Krishnamoorthy; Estella S Poloni
Journal:  BMC Genet       Date:  2008-02-27       Impact factor: 2.797

8.  NAT2 gene polymorphisms in three indigenous groups in the Colombian Caribbean Coast region.

Authors:  Isis Arias; Nelly Lecompte; Lila Visbal; Iliana Curiel; Enio Hernández; Pilar Garavito; Carlos Silvera-Redondo
Journal:  Colomb Med (Cali)       Date:  2014-12-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.